Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Eksioglu

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Viral Hepatitis|January 7, 2010
Hepatitis C virus modulates human monocyte-derived dendritic cellsE A Eksioglu, J R Bess, H Zhu, et al.
Scandinavian Journal of Immunology|October 2, 2010
Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinomaR Cabrera, M Ararat, E A Eksioglu, et al.
Leukemia|January 19, 2017
Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858E A Eksioglu, X Chen, K-H Heider, et al.
Oncogene|April 25, 2012
Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletionS Wei, X Chen, K McGraw, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Viral Hepatitis|January 7, 2010
Hepatitis C virus modulates human monocyte-derived dendritic cellsE A Eksioglu, J R Bess, H Zhu, et al.
Scandinavian Journal of Immunology|October 2, 2010
Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinomaR Cabrera, M Ararat, E A Eksioglu, et al.
Leukemia|January 19, 2017
Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858E A Eksioglu, X Chen, K-H Heider, et al.
Oncogene|April 25, 2012
Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletionS Wei, X Chen, K McGraw, et al.
Pageof 1